Unitedhealth Gp SEC Filings

Timothy P. Flynn, a director of UnitedHealth Group Inc. (UNH), received 272 deferred stock units on 10/01/2025 as regular quarterly director compensation at a reported price of $0. The filing shows 9,810 shares beneficially owned following the transaction and an additional 6,033 shares held indirectly by trust. The form explains these deferred stock units are immediately vested but must be retained until the director leaves the board. The Form 4 was signed by an attorney-in-fact and dated 10/03/2025.

UnitedHealth Group (UNH) director Kristen L. Gil received 162 shares of common stock as regular quarterly director compensation on 10/01/2025 at no cash price reported. After the grant, Ms. Gil directly beneficially owns 1,900 shares and indirectly owns 3,800 shares through a trust. The Form 4 was signed by an attorney-in-fact on 10/03/2025. The filing identifies the reporting person as a director and notes the shares were granted as routine director compensation.

UnitedHealth Group (UNH) director Valerie C. Montgomery Rice, M.D. was granted 270 deferred stock units on 10/01/2025 as part of regular quarterly director compensation. The units are immediately vested but must be held until she leaves the board. After the grant, her reported beneficial ownership of common stock is 6,897 shares, held directly. The Form 4 was signed by an attorney-in-fact on 10/03/2025.

This Form 4 reports that Charles D. Baker, a director of UnitedHealth Group Inc. (UNH), was granted 260 deferred stock units as director compensation on 10/01/2025. The units were granted at a $0 per-unit price and are described as immediately vested but required to be retained until the director leaves the Board. After the reported grant, the filing shows 1,516 shares (or equivalent units) beneficially owned by Mr. Baker. The form was signed by Faraz A. Choudhry, Attorney-in-Fact on 10/03/2025.

Michele J. Hooper, a director of UnitedHealth Group (UNH), was granted 162 deferred stock units on 10/01/2025 as regular quarterly director compensation. The grant was recorded at a reported price of $0 and increases her reported beneficial ownership to 40,877 shares following the transaction. The filing states the deferred stock units are immediately vested but must be retained until the director ends service on the Board. The Form 4 was signed by an attorney-in-fact and dated 10/03/2025.

John H. Noseworthy, a director of UnitedHealth Group Inc. (UNH), reported acquisition of 261 deferred stock units on 10/01/2025 as part of regular quarterly director compensation. The units were granted at $0 (deferred awards) and are immediately vested but must be held until the director leaves the Board. After the transaction, Dr. Noseworthy beneficially owns 6,693 shares (direct). The Form 4 was signed by attorney-in-fact Faraz A. Choudhry on 10/03/2025. The filing indicates this is a single reporting person filing and identifies the reporter as a Director of the issuer.

Timothy J. Noel, Chief Executive Officer, UHC, reported a non-derivative acquisition of common stock for UNITEDHEALTH GROUP INC (UNH) dated 09/23/2025. The transaction is coded A and is described as dividend equivalents paid on outstanding restricted stock units, which follow the same vesting terms as the underlying RSUs and are forfeited if the RSUs do not vest. The filing records a $0 price for the acquisition and shows 9,286.339 shares beneficially owned following the reported transaction(s). The form was signed by an attorney-in-fact on behalf of Mr. Noel on 09/25/2025.

Wayne S. DeVeydt, Chief Financial Officer of UnitedHealth Group Inc. (UNH), reported a non-derivative acquisition on 09/23/2025 of 66.899 shares of common stock. The filing states these shares represent dividend equivalents paid on outstanding restricted stock units and were recorded at a $0 price because they are dividend-equivalent awards rather than open-market purchases. After the transaction, Mr. DeVeydt beneficially owned 10,591.899 shares. The filing notes the dividend equivalents are subject to the same vesting and forfeiture terms as the underlying restricted stock units.

Kristen L. Gil, a director of UnitedHealth Group Inc. (UNH), reported a non-derivative acquisition on 09/23/2025 consisting of 7 shares credited as dividend equivalents on vested deferred stock units; these dividend equivalents vested immediately and follow the same terms as the underlying units. After the transaction Ms. Gil is shown as beneficially owning 1,738 shares directly and 3,800 shares indirectly through a trust. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/25/2025.